SOPAX | VIVIX | SOPAX / VIVIX | |
Total Expense Ratio | 1.00 | 0.04 | 2,500% |
Annual Report Gross Expense Ratio | 1.00 | 0.04 | 2,500% |
Fund Existence | 33 years | 27 years | - |
Gain YTD | 8.485 | 9.748 | 87% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.94B | 208B | 4% |
Annual Yield % from dividends | 1.10 | 2.09 | 52% |
Returns for 1 year | -0.81 | 4.64 | -18% |
Returns for 3 years | 29.48 | 42.98 | 69% |
Returns for 5 years | 34.54 | 71.78 | 48% |
Returns for 10 years | 82.94 | 129.40 | 64% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CCERX | 29.96 | 0.17 | +0.57% |
Columbia Large Cap Enhanced Core R | |||
GSWPX | 24.21 | 0.07 | +0.29% |
Goldman Sachs Small/Mid Cap Growth P | |||
RGACX | 84.70 | 0.17 | +0.20% |
American Funds Growth Fund of Amer R3 | |||
FSAAX | 17.53 | N/A | N/A |
Fidelity Advisor Asset Manager 60% A | |||
TMITX | 11.22 | -0.01 | -0.09% |
Transamerica Mid Cap Growth I3 |